BioWorld MedTech

Sep. 20, 2013

Crosstrees gains FDA clearance for PVA device

Crosstrees Medical (Boulder, Colorado) reported that it has received 510(k) clearance from the FDA for the Crosstrees PVA Pod System for Percutaneous Vertebral Augmentation (PVA). Read More

Agilent Technologies to split into two public companies

Device China annual conference: China device association calls for government guidance

Washington roundup: ReSure hits efficacy endpoint; protocol deviations a problem

Financings roundup: Infraredx gets $25M TVC imagingsystem investment from Nipro

Agreements/contracts: Ventana collaborates with Boehringer for diagnostics

Restructuring roundup: Citing ACA, Cleveland Clinic to cut $300M, warns of layoffs

Court report: Alleged secret deal finds Boston Sci facing hefty suit

HIT roundup: Bruker unveils ParaVision 6 preclinical MRI software

Deals roundup: IPC in plan to acquire the assets of MPHM

Med-Tech Notes

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...